Secor Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,088
Closed -$245K 546
2017
Q4
$245K Buy
+1,088
New +$232K 0.01% 432
2016
Q3
Sell
-6,735
Closed -$884K 554
2016
Q2
$884K Buy
6,735
+4,942
+276% +$676K 0.11% 267
2016
Q1
$249K Buy
+1,793
New +$240K 0.03% 487
2015
Q1
Sell
-9,759
Closed -$1.23M 471
2014
Q4
$1.23M Buy
+9,759
New +$1.21M 0.51% 45

Other funds holding ELV

Secor Capital Advisors's ELV Position: Q1 2018 in Review

Secor Capital Advisors sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 1,088 shares — an estimated $245K sold.

Secor Capital Advisors first reported a position in ELV in Q4 2014 and held it in 4 quarters. The position peaked at $1.23M in Q4 2014. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Secor Capital Advisors reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 1,088 Elevance Health shares in Q1 2018, an estimated $245K.
  • Secor Capital Advisors first reported a position in Elevance Health in Q4 2014 and held it in 4 quarters.
  • Secor Capital Advisors's Elevance Health position peaked at $1.23M in Q4 2014.
  • 924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Secor Capital Advisors's 13F filing for Q1 2018, filed 15 May 2018.